SCHEMBL18668986

SCHEMBL18668986

Nc1cccc2c1C(=O)N(Cc1ccc(Cl)c(Cl)c1)C2=O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.73
KDM4E B2RXH2 3/20 0.73
MAPK1 P28482 2/20 0.73
KMT2A Q03164 4/20 0.61
ALDH1A1 P00352 3/20 0.61
MEN1 O00255 3/20 0.61
POLB P06746 1/20 0.61
HPGD P15428 1/20 0.61
ATM Q13315 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
APAF1 O14727 3/20 0.56
ALOX15 P16050 2/20 0.56
HSD17B10 Q99714 2/20 0.56
ACHE P22303 2/20 0.56
TP53 P04637 1/20 0.56
CYP1A2 P05177 1/20 0.56
BCHE P06276 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18668985 0.84 ALDH1A1 (0.70) MAPTKMT2AALDH1A1MEN1SMN1; SMN2
SCHEMBL18688197 0.82 MAPT (0.76) MAPTKDM4EMAPK1KMT2AALDH1A1
SCHEMBL18669037 0.81 CA9 (0.67) MAPTKDM4EMAPK1KMT2AALDH1A1
SCHEMBL1837584 0.80 ALOX15 (0.68) MAPTKDM4EMAPK1KMT2AALDH1A1
SCHEMBL18668947 0.80 KDM4E (0.63) MAPTKDM4EMAPK1KMT2AALDH1A1
SCHEMBL18669089 0.80 KDM4E (0.67) MAPTKDM4EMAPK1KMT2AALDH1A1
SCHEMBL5780425 0.79 KDM4E (0.63) MAPTKDM4EMAPK1KMT2AALDH1A1
SCHEMBL18669019 0.79 MAPT (0.50) MAPTKDM4EMAPK1KMT2AALDH1A1
SCHEMBL16862967 0.78 KDM4E (0.66) MAPTKDM4EMAPK1KMT2AALDH1A1
SCHEMBL18669229 0.78 AHR (0.47) MAPTKDM4EMAPK1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017049409-A1 COMPOSITIONS FOR PROMOTING READTHROUGH OF PREMATURE TERMINATION CODONS, AND METHODS OF USING THE SAME THE CENTRE FOR DRUG RESEARCH AND DEVELOPMENT (CA) 2017-03-30 WO disclosed
WO-2017049409-A1 COMPOSITIONS FOR PROMOTING READTHROUGH OF PREMATURE TERMINATION CODONS, AND METHODS OF USING THE SAME THE CENTRE FOR DRUG RESEARCH AND DEVELOPMENT (CA) 2017-03-30 WO disclosed